会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明申请
    • CCR5 ANTAGONISTS USEFUL FOR TREATING HIV
    • CCR5有效治疗艾滋病毒的拮抗剂
    • US20070203149A1
    • 2007-08-30
    • US11677889
    • 2007-02-22
    • Ragulan RamanathanMichael MillerSwapan ChowdhuryKevin AltonDiane GrotzDiane RindgenAmol Tendolkar
    • Ragulan RamanathanMichael MillerSwapan ChowdhuryKevin AltonDiane GrotzDiane RindgenAmol Tendolkar
    • A61K31/506A61K31/551C07D403/14A61K31/522
    • C07D401/14C07D409/14
    • In its many embodiments, the present invention provides a novel class of compounds of structural formula I as inhibitors of the CCR5 receptors, methods of preparing such compounds, pharmaceutical compositions containing one or more such compounds, methods of preparing pharmaceutical formulations comprising one or more such compounds, and methods of treatment, prevention, inhibition, or amelioration of one or more diseases associated with CCR5 using such compounds or pharmaceutical compositions. The invention also relates to the use of a combination of a compound of this invention and one or more antiviral or other agents useful in the treatment of Human Immunodeficiency Virus (HIV). The invention further relates to the use of a compound of this invention, alone or in combination with another agent, in the treatment of solid organ transplant rejection, graft v. host disease, arthritis, rheumatoid arthritis, inflammatory bowel disease, atopic dermatitis, psoriasis, asthma, allergies or multiple sclerosis.
    • 在其许多实施方案中,本发明提供了一类新颖的结构式I化合物作为CCR5受体的抑制剂,制备这些化合物的方法,含有一种或多种这类化合物的药物组合物,制备药物制剂的方法,其包含一种或多种这样的化合物 化合物,以及使用这些化合物或药物组合物治疗,预防,抑制或改善与CCR5相关的一种或多种疾病的方法。 本发明还涉及本发明化合物与一种或多种可用于治疗人类免疫缺陷病毒(HIV)的抗病毒剂或其它药剂的组合的用途。 本发明还涉及本发明化合物单独或与另一种药剂组合用于治疗实体器官移植排斥,移植物抗宿主病,关节炎,类风湿性关节炎,炎症性肠病,特应性皮炎,牛皮癣 ,哮喘,过敏或多发性硬化。